Examining the mutant PSEN2 (N141I (Volga) and M239V) and APP (V717G, V717L, V717I, V717F and A713T) cohorts shows that a large proportion of carriers presented with dementia later than expected for PSEN2, and earlier than expected for APP, based on biochemical AAOs. This evidence concerns the gene APP and dementia.